Your browser doesn't support javascript.
loading
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts.
Isgren, Anniella; Göteson, Andreas; Holmén-Larsson, Jessica; Pelanis, Aurimantas; Sellgren, Carl; Joas, Erik; Sparding, Timea; Zetterberg, Henrik; Smedler, Erik; Jakobsson, Joel; Landén, Mikael.
Afiliação
  • Isgren A; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden. anniella.isgren@gu.se.
  • Göteson A; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Holmén-Larsson J; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Pelanis A; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Sellgren C; Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Joas E; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • Sparding T; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Smedler E; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, Gothenburg and Mölndal, Gothenburg, Sweden.
  • Jakobsson J; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
  • Landén M; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Gothenburg, Sweden.
Mol Psychiatry ; 27(11): 4568-4574, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35986174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia